Joshua Yang | Source | Co-Founder & CEO at Glyphic Biotechnologies
Joshua Yang
Co-Founder & CEO at Glyphic Biotechnologies
On the record
Bio
Joshua is the co-founder and CEO of Glyphic Biotechnologies, a VC-funded biotechnology startup commercializing a next-generation protein sequencing platform. His first startup Nephrosant has raised over $22M in funding to commercialize a low-cost, non-invasive diagnostic assay for kidney injury.
Recent Quotes
Sign up to view all
-
The activity in this space is insane. My co-founder and I really want to be the next Illumina or 10X Genomics — we really want to be that leader in proteomics.
30 July 2021
Media
Sign up to view all
-
30 July 2021article
Glyphic Biotechnologies raises $6M to accelerate protein sequencing by orders of magnitude – TechCrunchThe whole human proteome may be free to browse thanks to DeepMind, but at the bleeding edge of biotech new proteins are made and tested every day, a complex and time-consuming process. Glyphic Biotechnologies accelerates the critical but slow sequencing step, potentially cutting drug development ti…
Employment
Sign up to view all
-
Glyphic Biotechnologies
Co-Founder & CEO
Twitter Feed